Skip to content
Recall Observatory FDA recall evidence

Exact FDA event identifier

Event 62127

2 recalled-product records grouped only because every row carries this exact official event ID.

Open FDA event record

Event summary

Timeline bucket
June 13, 2012
Product types
Device
Classifications
Class II
Statuses
Terminated
Recalling firm wording
Genzyme Corporation

Dossier provenance

Source snapshots represented here

  • openFDA Device Enforcement Report-date coverage June 20, 2012–July 08, 2026 Known gap: openFDA describes 2004-present coverage, but the current export has no report-date records in this interval.
  • openFDA Device Recall event_date_initiated coverage June 01, 1997–June 30, 2026

Enforcement coverage uses report dates; product initiation dates can precede those bounds. Device-enrichment coverage uses FDA event_date_initiated.

How coverage and grouping work

Complete imported group

Every recalled product in this event

2 official enforcement rows

Product dates, classifications, firms, and source wording remain attached to their individual rows. Opening this dossier never hides products that did not match a prior timeline filter.

device · product 1 of 2

seprafilm¿ Procedure Pack ADHESION BARRIER Re-order Number: 5086-02 Product Usage: Seprafilm Adhesion Barrier is indicated for use in patients undergoing abdominal or pelvic laparotomy as an adjunct intended to reduce the incidence, extent and severity of postoperative adhesions between the abdominal wall and the underlying viscera such as omentum, small bowel, bladder, and stomach, and between the uterus and surrounding structures such as tubes and ovaries, large bowel, and bladder.

Z-1855-2012
Recall number
Z-1855-2012
Initiated
June 13, 2012
Classification
Class II
Status
Terminated
Recalling firm
Genzyme Corporation
Quantity
3880units

App-derived interpretation

Labeling or packaging reason.labeling_packaging · v1.0.0
packaging defect
Sterility assurance reason.sterility_assurance · v1.0.0
Sterility of product may be compromised due to packaging defect

These labels are deterministic app interpretations, not FDA categories.

Official device-enrichment evidence · Sourced

Packaging process control

Compare all device evidence states

Inspect official wording and provenance

Reason for recall

Sterility of product may be compromised due to packaging defect

Code information

Lot numbers: 11NP620 Exp. 2014 - 09; 11NP630 Exp 2014 - 10; and 11NP649 Exp 2014- 11; 11NP704 Exp 2014 - 11

Distribution pattern

Worldwide Distribution - US (nationwide) and the country of S. Korea

device · product 2 of 2

seprafilm¿ Single Site ADHESION BARRIER Re-order Number: 6641-01 Product Usage: Seprafilm Adhesion Barrier is indicated for use in patients undergoing abdominal or pelvic laparotomy as an adjunct intended to reduce the incidence, extent and severity of postoperative adhesions between the abdominal wall and the underlying viscera such as omentum, small bowel, bladder, and stomach, and between the uterus and surrounding structures such as tubes and ovaries, large bowel, and bladder.

Z-1856-2012
Recall number
Z-1856-2012
Initiated
June 13, 2012
Classification
Class II
Status
Terminated
Recalling firm
Genzyme Corporation
Quantity
1285 units

App-derived interpretation

Labeling or packaging reason.labeling_packaging · v1.0.0
packaging defect
Sterility assurance reason.sterility_assurance · v1.0.0
Sterility of product may be compromised due to packaging defect

These labels are deterministic app interpretations, not FDA categories.

Official device-enrichment evidence · Sourced

Packaging process control

Compare all device evidence states

Inspect official wording and provenance

Reason for recall

Sterility of product may be compromised due to packaging defect

Code information

Lot number: 11NP685 . Exp 2014- 11

Distribution pattern

Worldwide Distribution - US (nationwide) and the country of S. Korea